News

Santanu Chakrabarti, India BFSI Analyst at BNP Paribas, noted investor frustration with Axis Bank’s repeated underperformance but sees value in its strong CASA base and attractive valuation of 1.6x ...
Axis Securities offers a bullish outlook on Bajaj Finance with a 14% upside target—discover why it's a potential Buy now!
The first-quarter earnings season is in full swing, and over the past week, the spotlight has stuck on the banking sector. Lending giants HDFC Bank, ICICI Bank and Axis Bank have all posted their ...
Key Points Alibaba is a Chinese AI stock that's dirt cheap. Meta Platforms is making a huge bet on AI that should pay off handsomely. Vertex Pharmaceuticals is expanding into new indications.
A literature survey and theoretical calculations have been applied to explore bilateral symmetry in natural product systems. Molecular bilateral symmetry is defined to include C2 (sigma plane or axis) ...
Following our analysis of the options activities associated with Vertex Pharmaceuticals, we pivot to a closer look at the company's own performance. Where Is Vertex Pharmaceuticals Standing Right Now?